Iceutica Operations Company Profile

What is the competitive landscape for ICEUTICA OPERATIONS, and what generic alternatives to ICEUTICA OPERATIONS drugs are available?

ICEUTICA OPERATIONS has one approved drug.

There are three US patents protecting ICEUTICA OPERATIONS drugs.

There are sixteen patent family members on ICEUTICA OPERATIONS drugs in sixteen countries.

Summary for Iceutica Operations

International Patents:	16
US Patents:	3
Tradenames:	1
Ingredients:	1
NDAs:	1

Drugs and US Patents for Iceutica Operations

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Iceutica Operations	VIVLODEX	meloxicam	CAPSULE;ORAL	207233-001	Oct 22, 2015		DISCN	Yes	No	9,649,318		Y
Iceutica Operations	VIVLODEX	meloxicam	CAPSULE;ORAL	207233-001	Oct 22, 2015		DISCN	Yes	No	9,526,734		Y
Iceutica Operations	VIVLODEX	meloxicam	CAPSULE;ORAL	207233-001	Oct 22, 2015		DISCN	Yes	No	9,808,468
Iceutica Operations	VIVLODEX	meloxicam	CAPSULE;ORAL	207233-002	Oct 22, 2015		DISCN	Yes	No	9,526,734		Y
Iceutica Operations	VIVLODEX	meloxicam	CAPSULE;ORAL	207233-002	Oct 22, 2015		DISCN	Yes	No	9,649,318		Y
Iceutica Operations	VIVLODEX	meloxicam	CAPSULE;ORAL	207233-002	Oct 22, 2015		DISCN	Yes	No	9,808,468

Paragraph IV (Patent) Challenges for ICEUTICA OPERATIONS drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
	Capsules	5 mg and 10 mg		2017-01-09

International Patents for Iceutica Operations Drugs

Country	Patent Number	Estimated Expiration
Morocco	39443
World Intellectual Property Organization (WIPO)	2015191595
South Africa	201700022
Canada	2951383
Uruguay	36172
New Zealand	726610

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Iceutica Operations